Inovio Interest Expense vs Total Other Income Expense Net Analysis

INO Stock  USD 11.50  0.93  8.80%   
Inovio Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Inovio Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Inovio Pharmaceuticals is a good investment. Please check the relationship between Inovio Pharmaceuticals Interest Expense and its Total Other Income Expense Net accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.

Interest Expense vs Total Other Income Expense Net

Interest Expense vs Total Other Income Expense Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Inovio Pharmaceuticals Interest Expense account and Total Other Income Expense Net. At this time, the significance of the direction appears to have pay attention.
The correlation between Inovio Pharmaceuticals' Interest Expense and Total Other Income Expense Net is -0.74. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Inovio Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Inovio Pharmaceuticals' Interest Expense and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Inovio Pharmaceuticals are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Interest Expense i.e., Inovio Pharmaceuticals' Interest Expense and Total Other Income Expense Net go up and down completely randomly.

Correlation Coefficient

-0.74
Relationship DirectionNegative 
Relationship StrengthWeak

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Other Income Expense Net

Most indicators from Inovio Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Inovio Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.At this time, Inovio Pharmaceuticals' Selling General Administrative is very stable compared to the past year. As of the 30th of April 2024, Sales General And Administrative To Revenue is likely to grow to 60.05, while Issuance Of Capital Stock is likely to drop about 9.8 M.
 2021 2022 2023 2024 (projected)
Total Revenue1.8M10.3M832.0K790.4K
Interest Expense1.9M1.3M1.2M1.2M

Inovio Pharmaceuticals fundamental ratios Correlations

-0.340.710.970.77-0.62-0.530.410.790.671.00.75-0.210.320.880.650.630.611.0-0.360.68-0.290.110.630.08-0.32
-0.34-0.26-0.35-0.20.10.57-0.31-0.210.35-0.38-0.130.680.0-0.5-0.59-0.15-0.5-0.40.8-0.350.81-0.21-0.170.11-0.51
0.71-0.260.590.66-0.11-0.670.850.260.390.690.59-0.060.290.810.690.780.520.72-0.330.43-0.150.230.110.19-0.38
0.97-0.350.590.63-0.75-0.430.290.830.620.970.74-0.140.110.820.580.420.520.97-0.310.62-0.360.060.67-0.08-0.27
0.77-0.20.660.63-0.14-0.570.360.460.670.760.46-0.170.70.620.610.850.770.75-0.410.710.080.210.390.57-0.3
-0.620.1-0.11-0.75-0.14-0.070.09-0.9-0.5-0.61-0.66-0.050.21-0.47-0.080.070.05-0.610.02-0.320.210.07-0.840.260.09
-0.530.57-0.67-0.43-0.57-0.07-0.52-0.16-0.12-0.54-0.250.31-0.3-0.58-0.98-0.59-0.85-0.550.55-0.580.44-0.19-0.09-0.240.35
0.41-0.310.850.290.360.09-0.520.010.040.390.31-0.160.180.730.50.610.240.44-0.330.14-0.250.12-0.130.1-0.13
0.79-0.210.260.830.46-0.9-0.160.010.650.780.7-0.220.220.620.310.30.230.77-0.220.58-0.240.010.950.02-0.17
0.670.350.390.620.67-0.5-0.120.040.650.620.690.270.440.390.230.520.310.610.180.450.370.070.620.31-0.62
1.0-0.380.690.970.76-0.61-0.540.390.780.620.71-0.240.30.870.670.60.631.0-0.410.69-0.340.10.610.06-0.29
0.75-0.130.590.740.46-0.66-0.250.310.70.690.710.090.10.630.370.410.210.73-0.080.3-0.080.150.65-0.08-0.25
-0.210.68-0.06-0.14-0.17-0.050.31-0.16-0.220.27-0.240.09-0.43-0.4-0.31-0.32-0.3-0.250.49-0.370.72-0.19-0.210.0-0.38
0.320.00.290.110.70.21-0.30.180.220.440.30.1-0.430.270.270.830.440.29-0.280.480.20.130.230.67-0.19
0.88-0.50.810.820.62-0.47-0.580.730.620.390.870.63-0.40.270.670.650.480.89-0.420.59-0.50.140.470.03-0.17
0.65-0.590.690.580.61-0.08-0.980.50.310.230.670.37-0.310.270.670.580.870.67-0.560.64-0.480.180.210.19-0.36
0.63-0.150.780.420.850.07-0.590.610.30.520.60.41-0.320.830.650.580.60.61-0.380.570.040.220.210.55-0.34
0.61-0.50.520.520.770.05-0.850.240.230.310.630.21-0.30.440.480.870.60.62-0.540.72-0.280.220.150.35-0.28
1.0-0.40.720.970.75-0.61-0.550.440.770.611.00.73-0.250.290.890.670.610.62-0.410.68-0.350.110.610.05-0.28
-0.360.8-0.33-0.31-0.410.020.55-0.33-0.220.18-0.41-0.080.49-0.28-0.42-0.56-0.38-0.54-0.41-0.410.41-0.04-0.13-0.22-0.41
0.68-0.350.430.620.71-0.32-0.580.140.580.450.690.3-0.370.480.590.640.570.720.68-0.41-0.260.250.510.49-0.28
-0.290.81-0.15-0.360.080.210.44-0.25-0.240.37-0.34-0.080.720.2-0.5-0.480.04-0.28-0.350.41-0.26-0.14-0.190.37-0.28
0.11-0.210.230.060.210.07-0.190.120.010.070.10.15-0.190.130.140.180.220.220.11-0.040.25-0.140.070.160.07
0.63-0.170.110.670.39-0.84-0.09-0.130.950.620.610.65-0.210.230.470.210.210.150.61-0.130.51-0.190.070.08-0.1
0.080.110.19-0.080.570.26-0.240.10.020.310.06-0.080.00.670.030.190.550.350.05-0.220.490.370.160.08-0.16
-0.32-0.51-0.38-0.27-0.30.090.35-0.13-0.17-0.62-0.29-0.25-0.38-0.19-0.17-0.36-0.34-0.28-0.28-0.41-0.28-0.280.07-0.1-0.16
Click cells to compare fundamentals

Inovio Pharmaceuticals Account Relationship Matchups

Inovio Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets144.0M539.8M495.9M348.5M172.9M131.2M
Total Current Liabilities32.0M41.7M65.7M96.9M42.6M23.4M
Total Stockholder Equity3.4M461.1M399.7M222.4M117.3M95.2M
Property Plant And Equipment Net26.6M24.1M29.0M18.0M14.5M7.5M
Net Debt77.3M(211.7M)(38.1M)(14.3M)15.9M16.7M
Retained Earnings(739.8M)(906.2M)(1.2B)(1.5B)(1.6B)(1.5B)
Accounts Payable7.6M1.5M24.8M80.9M4.6M7.3M
Cash22.2M250.7M71.1M46.3M14.3M13.6M
Non Current Assets Total49.8M68.6M47.5M33.3M19.8M28.2M
Cash And Short Term Investments89.5M411.6M401.3M253.0M145.3M92.0M
Net Receivables2.0M19.1M8.0M11.7M2.4M3.9M
Common Stock Shares Outstanding8.2M12.9M17.4M19.9M22.2M28.0M
Liabilities And Stockholders Equity144.0M539.8M495.9M348.5M172.9M131.2M
Non Current Liabilities Total106.6M36.9M30.5M29.3M13.0M12.1M
Other Current Assets2.6M40.5M39.1M50.5M5.4M6.9M
Other Stockholder Equity742.6M1.4B1.6B1.7B1.7B1.8B
Total Liab138.5M78.6M96.3M126.2M55.6M35.5M
Property Plant And Equipment Gross26.6M24.1M48.0M18.0M35.3M37.1M
Total Current Assets94.2M471.2M448.4M315.2M153.1M103.0M
Accumulated Other Comprehensive Income472.6K(256.2K)(282.2K)(698.7K)(662.6K)(629.5K)
Intangible Assets3.7M3.1M2.6M2.1M2.4M2.3M
Other Current Liab22.1M37.9M38.4M13.2M18.7M19.7M
Other Liab9.1M206.4K111.2K32.0K36.9K35.0K
Non Currrent Assets Other(5.4M)22.2M(1.5M)(1.6M)605.3K635.6K
Other Assets2.7M43.6M1.4M684.0K1.00.95
Common Stock Total Equity101.4K186.9K217.4K253.1K227.8K216.4K
Common Stock101.4K186.9K217.4K253.1K22.8K21.7K
Property Plant Equipment12.8M11.3M17.5M7.7M8.9M5.2M
Current Deferred Revenue257.2K124.1K46.6K21.6K24.9K23.6K
Short Term Investments67.3M160.9M330.2M206.7M131.0M85.0M
Net Tangible Assets(10.8M)447.5M386.5M209.7M241.2M159.6M
Retained Earnings Total Equity(739.8M)(906.2M)(1.2B)(1.5B)(1.3B)(1.3B)
Capital Surpluse742.6M1.4B1.6B1.7B2.0B2.1B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Inovio Stock analysis

When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.09)
Revenue Per Share
0.038
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.32)
Return On Equity
(0.80)
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.